Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

61.93 +1.62 (+2.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,980,973
Open 63.33
Bid (Size) 61.40 (3)
Ask (Size) 64.89 (1)
Prev. Close 60.31
Today's Range 58.72 - 63.97
52wk Range 52.93 - 94.85
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
BioMarin beats Q2 expectations on strong enzyme therapy sales and raises full-year earnings and revenue guidance amid continued Voxzogo growth. 
Via Benzinga
BioMarin (BMRN) Q2 Revenue Jumps 16%
Via The Motley Fool
Topics Economy

Performance

YTD
-6.9%
-6.9%
1 Month
+7.9%
+7.9%
3 Month
-0.2%
-0.2%
6 Month
-0.8%
-0.8%
1 Year
-23.0%
-23.0%

More News

Read More
BioMarin (BMRN) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Strong Q2 Numbers, Stock Soars
Via StockStory
Earnings Scheduled For August 4, 2025
Via Benzinga
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Exceeds Q2 2025 Earnings Expectations, Shares Climb After Hours
Via Chartmill
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence Economy World Trade
What's Next: Biomarin Pharmaceutical's Earnings Preview
Via Benzinga
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
Via Benzinga
1 Mid-Cap Stock Worth Investigating and 2 We Turn Down
Via StockStory
What Does the Market Think About BioMarin Pharmaceutical?
Via Benzinga
Demystifying BioMarin Pharmaceutical: Insights From 4 Analyst Reviews
Via Benzinga
1 Cash-Producing Stock to Consider Right Now and 2 We Ignore
Via StockStory
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock Worth Watching
Via Chartmill
Nasdaq Bull Market: 3 Historically Cheap Stocks That Can Easily Double Your Money
Via The Motley Fool
Topics Economy Stocks
Unpacking Q1 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock With Strong Fundamentals
Via Chartmill
2 Profitable Stocks for Long-Term Investors and 1 to Be Wary Of
Via StockStory
2 Reasons to Watch BMRN and 1 to Stay Cautious
Via StockStory
Topics Stocks
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Via Benzinga
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
Via The Motley Fool
Topics Stocks
1 Mid-Cap Stock with Exciting Potential and 2 to Avoid
Via StockStory
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock Worth Watching
Via Chartmill
Top movers in Friday's after hours session
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)
From Brodsky & Smith LLC
Via GlobeNewswire

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 61.93
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 08/05/25 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 11.36B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.